Evidence map›Paper›PMID 12872122›Full record

ArticleNature genetics2003

Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis.

Heike Olbrich, Manfred Fliegauf, Julia Hoefele, Andreas Kispert, Edgar Otto, Andreas Volz, Matthias T Wolf, Gürsel Sasmaz, Ute Trauer, Richard Reinhardt and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 2 syntheses or guidelines pooled it, 365 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Renal Tubule-Specific Deletion of Nephrocystin 3International journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Nephronophthisis: a pathological and genetic perspective.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Contextual modifiers of healthspan, lifespan, and epigenome in mice under chronic social stress.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Heike OlbrichDepartment of Pediatrics and Adolescent Medicine, University Hospital Freiburg, 79106 Freiburg, Germany.
Manfred Fliegauf
Julia Hoefele
Andreas Kispert
Edgar Otto
Andreas Volz
Matthias T Wolf
Gürsel Sasmaz
Ute Trauer
Richard Reinhardt
Ralf Sudbrak
Corinne Antignac
Norbert Gretz
Gerd Walz
Bernhard Schermer
Thomas Benzing
Friedhelm Hildebrandt
Heymut Omran
University of Freiburg · DEUniversity of Michigan · USMax Planck Society · DEHeidelberg University · DEInserm · FRMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephronophthisis (NPHP), a group of autosomal recessive cystic kidney disorders, is the most common genetic cause of progressive renal failure in children and young adults. NPHP may be associated with Leber congenital amaurosis, tapeto-retinal degeneration, cerebellar ataxia, cone-shaped epiphyses, congenital oculomotor apraxia and hepatic fibrosis. Loci associated with an infantile type of NPHP on 9q22-q31 (NPHP2), juvenile types of NPHP on chromosomes 2q12-q13 (NPHP1) and 1p36 (NPHP4) and an adolescent type of NPHP on 3q21-q22 (NPHP3) have been mapped. NPHP1 and NPHP4 have been identified, and interaction of the respective encoded proteins nephrocystin and nephrocystin-4 has been shown. Here we report the identification of NPHP3, encoding a novel 1,330-amino acid protein that interacts with nephrocystin. We describe mutations in NPHP3 in families with isolated NPHP and in families with NPHP with associated hepatic fibrosis or tapeto-retinal degeneration. We show that the mouse ortholog Nphp3 is expressed in the node, kidney tubules, retina, respiratory epithelium, liver, biliary tract and neural tissues. In addition, we show that a homozygous missense mutation in Nphp3 is probably responsible for the polycystic kidney disease (pcy) mouse phenotype. Interventional studies in the pcy mouse have shown beneficial effects by modification of protein intake and administration of methylprednisolone, suggesting therapeutic strategies for treating individuals with NPHP3.

Indexed as

MutationAdaptor Proteins, Signal TransducingAdolescentAdultAnimalsCell LineChildCytoskeletal ProteinsDNA, ComplementaryFemaleHumansKidney Diseases, CysticLiver CirrhosisMaleMembrane ProteinsMiceAdaptor Proteins, Signal TransducingCytoskeletal ProteinsDNA, ComplementaryMembrane ProteinsNPHP1 protein, humanNPHP4 protein, humanProteinsRecombinant Proteins

Identifiers

PMID12872122
OpenAlexW1996445467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.